China TCM Warns of 2025 Loss on Weaker Granules Business and Higher Impairments
I'm PortAI, I can summarize articles.
China Traditional Chinese Medicine Holdings Co (HK:0570) has issued a profit warning, expecting a net loss of RMB350 million to RMB500 million for 2025, down from a small profit of RMB20.77 million in 2024. The decline is attributed to weaker performance in its TCM granules business, intensified competition, and increased impairments. Despite these challenges, management indicates that the adjustments are largely non-recurring and will not affect ongoing operations. The current analyst rating is a Hold with a price target of HK$2.00.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments